Possible Role of Beta-Hydroxybutyrate in Inducing Inflammation in Alopecia Areata

This study explores the role of beta-hydroxybutyrate (BHB) in the pathogenesis of alopecia areata (AA), an autoimmune inflammatory disease causing hair loss. Researchers found that serum BHB levels were significantly higher in AA patients compared to healthy controls, with levels correlating with the severity of hair loss. BHB treatment increased inflammatory cytokine production in outer root sheath cells, suggesting that elevated BHB may exacerbate inflammation in AA. The study indicates that serum BHB could serve as a marker for poor prognosis in severe AA cases, highlighting the need for further research to understand BHB's role in AA and its potential implications for treatment. The study involved 19 AA patients and 28 healthy controls.